Librela is an innovative solution for managing pain and inflammation caused by osteoarthritis in dogs. It significantly improves your pet’s mobility and quality of life after just one injection.
Active Ingredient:
Bedinvetmab — a monoclonal antibody that blocks nerve growth factor (NGF), which is responsible for pain transmission.
Form:
Solution for subcutaneous injection. Available in vials of 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg, depending on the dog's weight.
Administration:
Given once a month by a veterinary professional. Dosage is based on the dog’s body weight.
Benefits:
-
Fast and lasting pain relief
-
Improved activity and mobility
-
Suitable for long-term use
-
Convenient monthly injection
-
High safety and tolerance profile
Indications:
-
Chronic pain due to osteoarthritis in dogs
Contraindications:
-
Dogs under 12 months of age
-
Pregnancy and lactation
-
Hypersensitivity to any component
Note:
Librela must be used under veterinary supervision. Always consult your vet before use.
